HighTower Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56B Buy
10,484,201
+6,535,453
+166% +$1.52B 2.72% 2
2025
Q4
$817M Sell
3,948,748
-23,411
-0.6% -$4.63M 0.89% 14
2025
Q3
$737M Sell
3,972,159
-5,270
-0.1% -$903K 0.84% 14
2025
Q2
$608M Sell
3,977,429
-5,359
-0.1% -$824K 0.76% 17
2025
Q1
$661M Buy
3,982,788
+228,794
+6% +$35.8M 0.9% 12
2024
Q4
$543M Buy
3,753,994
+198,978
+6% +$30.8M 0.74% 17
2024
Q3
$576M Buy
3,555,016
+91,324
+3% +$14.6M 0.82% 13
2024
Q2
$506M Sell
3,463,692
-271,792
-7% -$40.4M 0.78% 15
2024
Q1
$591M Sell
3,735,484
-167,932
-4% -$26.7M 0.96% 12
2023
Q4
$612M Buy
3,903,416
+70,168
+2% +$10.8M 1.03% 9
2023
Q3
$597M Sell
3,833,248
-171,161
-4% -$28.2M 1.12% 10
2023
Q2
$663M Buy
4,004,409
+141,456
+4% +$22.8M 1.3% 9
2023
Q1
$599M Buy
3,862,953
+23,799
+0.6% +$3.84M 1.31% 7
2022
Q4
$678M Buy
3,839,154
+114,111
+3% +$19.7M 1.55% 6
2022
Q3
$608M Buy
3,725,043
+102,650
+3% +$17.4M 1.63% 6
2022
Q2
$644M Buy
3,622,393
+39,381
+1% +$7.02M 1.66% 5
2022
Q1
$635M Buy
3,583,012
+106,297
+3% +$18.1M 1.42% 7
2021
Q4
$595M Buy
3,476,715
+544,373
+19% +$89.1M 1.3% 6
2021
Q3
$473M Buy
2,932,342
+445,605
+18% +$76M 1.27% 8
2021
Q2
$409M Buy
2,486,737
+235,674
+10% +$39M 1.19% 7
2021
Q1
$370M Buy
2,251,063
+99,930
+5% +$16.2M 1.17% 7
2020
Q4
$339M Buy
2,151,133
+562,521
+35% +$83M 1.41% 7
2020
Q3
$236M Buy
1,588,612
+72,573
+5% +$10.7M 1.14% 7
2020
Q2
$213M Buy
1,516,039
+38,039
+3% +$5.54M 1.16% 8
2020
Q1
$194M Buy
1,478,000
+43,045
+3% +$6.11M 1.26% 8
2019
Q4
$209M Sell
1,434,955
-6,454
-0.4% -$875K 1.24% 4
2019
Q3
$187M Sell
1,441,409
-6,930
-0.5% -$913K 1.02% 9
2019
Q2
$202M Sell
1,448,339
-57,984
-4% -$8.03M 1.2% 5
2019
Q1
$211M Buy
1,506,323
+9,874
+0.7% +$1.32M 1.41% 5
2018
Q4
$193M Buy
1,496,449
+207,666
+16% +$29M 1.48% 5
2018
Q3
$178M Buy
1,288,783
+21,389
+2% +$2.84M 1.28% 4
2018
Q2
$154M Buy
1,267,394
+25,062
+2% +$3.13M 1.2% 4
2018
Q1
$159M Buy
1,242,332
+9,762
+0.8% +$1.32M 1.33% 4
2017
Q4
$172M Sell
1,232,570
-6,559
-0.5% -$914K 1.41% 4
2017
Q3
$161M Sell
1,239,129
-3,194
-0.3% -$423K 1.38% 4
2017
Q2
$164M Buy
1,242,323
+45,090
+4% +$5.75M 1.47% 4
2017
Q1
$149M Sell
1,197,233
-34,787
-3% -$4.16M 1.43% 4
2016
Q4
$142M Buy
1,232,020
+38,366
+3% +$4.43M 1.54% 5
2016
Q3
$141M Buy
1,193,654
+12,725
+1% +$1.54M 1.64% 4
2016
Q2
$143M Sell
1,180,929
-70,116
-6% -$7.97M 1.81% 2
2016
Q1
$135M Sell
1,251,045
-11,632
-0.9% -$1.2M 0.44% 7
2015
Q4
$130M Buy
1,262,677
+44,935
+4% +$4.52M 1.54% 4
2015
Q3
$114M Buy
1,217,742
+100,393
+9% +$9.71M 1.51% 2
2015
Q2
$109M Buy
1,117,349
+111,740
+11% +$11.2M 1.75% 2
2015
Q1
$101M Buy
1,005,609
+56,116
+6% +$5.71M 1.51% 3
2014
Q4
$99.3M Buy
949,493
+31,045
+3% +$3.27M 1.52% 3
2014
Q3
$97.9M Buy
918,448
+29,605
+3% +$3.07M 1.65% 3
2014
Q2
$93M Buy
888,843
+46,397
+6% +$4.69M 1.61% 3
2014
Q1
$82.8M Buy
842,446
+9,497
+1% +$880K 1.61% 3
2013
Q4
$76.3M Buy
832,949
+478,552
+135% +$44.1M 1.57% 4
2013
Q3
$30.7M Sell
354,397
-353,827
-50% -$31.7M 0.77% 19
2013
Q2
$60.8M Buy
+708,224
New +$60.1M 1.65% 3

Other funds holding JNJ

HighTower Advisors's JNJ Position: Q1 2026 in Review

HighTower Advisors increased its Johnson & Johnson (JNJ) stake by 166% in Q1 2026, buying an estimated $1.52B and bringing the position to 10,484,201 shares worth $2.56B. The position accounts for 2.72% of the portfolio, ranked #2.

HighTower Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • HighTower Advisors held 10,484,201 shares of Johnson & Johnson worth $2.56B as of Q1 2026.
  • HighTower Advisors bought 6,535,453 Johnson & Johnson shares in Q1 2026, an estimated $1.52B.
  • Johnson & Johnson made up 2.72% of HighTower Advisors's portfolio in Q1 2026, its #2 holding.
  • HighTower Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.